Maxim Group Maintains a Buy Rating on Semler Scientific (SMLR), Sets a $95 PT

Semler Scientific, Inc. (NASDAQ:SMLR) is one of the best medical device stocks to buy according to analystsAnalyst Matthew Galinko of Maxim Group maintained a Buy rating on  Semler Scientific, Inc. (NASDAQ:SMLR) on August 6, retaining the price target of $95.00.

A doctor in focus surrounded by colleagues in a hospital setting.

The analyst told investors that Semler Scientific, Inc. (NASDAQ:SMLR) has exhibited a strong commitment to the accumulation of Bitcoin, with a goal to hold 10,000 BTC by the end of 2025 and considerably more in the following years.

He added that Semler Scientific, Inc.’s (NASDAQ:SMLR) ability to raise considerable funds through share issuance further supports this accumulation strategy, suggesting a strong financial strategy.

Galinko further stated that Semler Scientific, Inc. (NASDAQ:SMLR) is also expanding its medical technology offerings, especially with the formation of CardioVanta, a subsidiary focused on cardiovascular market opportunities. The expected approval of new diagnostic devices may expand the company’s market reach, enhancing its revenue potential.

Semler Scientific, Inc. (NASDAQ:SMLR) provides technology and software solutions to improve the clinical effectiveness of healthcare providers. The company’s multi-test service platform, WellChec, conducts a comprehensive evaluation of patients for chronic disease, including strokes and heart attacks, through the use of its QuantaFlo product as well as other tests.

While we acknowledge the potential of SMLR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SMLR and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.